Encora Therapeutics today announced that Encora X1™, its FDA-cleared wearable for adults with essential tremor, is now ...
A committee of outside clinical trial observers has recommended that Praxis Precision Medicines stop testing its experimental treatment for essential tremor after an interim analysis of one study ...
Some people live with essential tremor for years and organically find ways to adapt. Others may begin avoiding activities.
Encora Therapeutics developed an FDA-cleared wearable treatment for essential tremor from a prototype originally created by ...
Praxis Precision Medicines plans to start a phase 3 trial of ulixacaltamide in essential tremor in the second half of the year. (asbe/iStock/Getty Images Plus) Praxis Precision Medicines isn’t letting ...
A noninvasive wristband delivers patterned vibrations to reduce essential tremor, with more than 70% of clinical trial ...